La Chaux-de-Fonds, Switzerland
La Chaux-de-Fonds, Switzerland

Time filter

Source Type

Patent
Ferring International Center S.A. | Date: 2012-10-03

The invention provides uses and dosing regimens of a gonadotrophin releasing hormone (GnRH) antagonist for the treatment of prostate cancer in a subject who is at risk for cardiovascular disease.


Patent
Ferring International Center Sa | Date: 2014-11-14

Preparations including recombinant FSH (rFSH).


Patent
Ferring International Center S.A. | Date: 2014-11-05

The invention provides uses and dosing regimens of a gonadotrophin releasing hormone (GnRH) antagonist for the treatment of prostate cancer.


Patent
Ferring International Center S.A. | Date: 2011-07-06

Disclosed are improved granular pharmaceutical preparations, together with improved methods and apparatus for preparation of granules for use in such preparations. Such methods are especially useful for making granules for solid oral dose pharmaceutical preparations, and are particularly suited to the production of granules comprising 5-aminosalicylic acid (5-ASA) for the treatment of inflammatory bowel disease. The granules exhibit a more sharply peaked length distribution, and hence aspect ratio distribution, and have a consequently much sharper dissolution profile after further processing.


Patent
Ferring International Center S.A. | Date: 2013-10-16

Compositions comprising degarelix for the treatment of metastatic stage prostate cancer in a subject are provided.


Patent
Ferring International Center SA | Date: 2016-08-16

Preparations including recombinant FSH (rFSH).


Patent
Ferring International Center S.A. | Date: 2013-12-20

A pharmaceutical composition comprising a docusate; an osmotic laxative; and a benzoate.


Patent
Ferring International Center S.A. | Date: 2010-09-21

The present invention relates to oxytocin receptor agonist compounds, pharmaceutical compositions comprising the same, use of such compounds for the manufacture of a medicament for treatment of inter alia, abdominal pain, irritable bowel syndrome (IBS), autism, erectile dysfunction, female sexual dysfunction, labor induction and maintenance, lactation induction and maintenance, postpartum hemorrhage, Post Traumatic Stress Disorder (PTSD), pain, anxiety and other conditions, as well as to methods for the treatment of such conditions, wherein such compounds are administered. The compounds are represented by the general formula (I), as further defined in the specification:


Patent
Ferring International Center S.A. | Date: 2014-11-17

The use of a dopamine agonist in the manufacture of a medicament for the treatment or prevention of endometriosis.


Patent
Ferring International Center S.A. | Date: 2011-09-27

A process for the preparation of a pharmaceutical composition comprising a homogeneous or substantially homogeneous mixture of citric acid, magnesium oxide, potassium bicarbonate and sodium picosulphate and, optionally, saccharin sodium and/or orange flavor; products, intermediate products, and uses thereof.

Loading Ferring International Center collaborators
Loading Ferring International Center collaborators